|
1
|
States JC, Barchowsky A, Cartwright IL,
Reichard JF, Futscher BW and Lantz RC: Arsenic toxicology:
translating between experimental models and human pathology.
Environ Health Perspect. 119:1356–1363. 2011. View Article : Google Scholar
|
|
2
|
Nickson RT, McArthur JM, Shrestha B,
Kyaw-Myint TO and Lowry D: Arsenic and other drinking water quality
issues, Muzaffargarh District, Pakistan. Appl Geochem. 20:55–68.
2005. View Article : Google Scholar
|
|
3
|
Uqaili AA, Mughal AH and Maheshwari BK:
Arsenic contamination in ground water sources of district Matiari,
Sindh. Int J Eng Res Appl. 3:259–266. 2012.
|
|
4
|
Ahmad SA, Gulzar A, Rehman HU, Soomro ZA,
Hussain M, Rehman MU and Qadir MA: Study of arsenic in drinking
water of distric Kasur Pakistan. World Appl Sci J. 24:634–640.
2013.
|
|
5
|
Ashraf M, Tariq J and Jaffar M: Contents
of trace metals in fish, sediment and water from three freshwater
reservoirs on the Indus River, Pakistan. Fish Res. 12:355–364.
1991. View Article : Google Scholar
|
|
6
|
Marchiset-Ferlay N, Savanovitch C and
Sauvant-Rochat MP: What is the best biomarker to assess arsenic
exposure via drinking water? Environ Int. 39:150–171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith AH, Goycolea M, Haque R and Biggs
ML: Marked increase in bladder and lung cancer mortality in a
region of Northern Chile due to arsenic in drinking water. Am J
Epidemiol. 147:660–669. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Biswas R, Ghosh P, Banerjee N, Das JK, Sau
T, Banerjee A, Roy S, Ganguly S, Chatterjee M, Mukherjee A and Giri
AK: Analysis of T-cell proliferation and cytokine secretion in the
individuals exposed to arsenic. Hum Exp Toxicol. 27:381–386. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banerjee N, Banerjee M, Ganguly S,
Bandyopadhyay S, Das JK, Bandyopadhay A, Chatterjee M and Giri AK:
Arsenic-induced mitochondrial instability leading to programmed
cell death in the exposed individuals. Toxicology. 246:101–111.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Banerjee N, Banerjee S, Sen R,
Bandyopadhyay A, Sarma N, Majumder P, Das JK, Chatterjee M, Kabir
SN and Giri AK: Chronic arsenic exposure impairs macrophage
functions in the exposed individuals. J Clin Immunol. 29:582–594.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luna AL, Acosta-Saavedra LC,
Lopez-Carrillo L, Conde P, Vera E, De Vizcaya-Ruiz A, Bastida M,
Cebrian ME and Calderon-Aranda ES: Arsenic alters monocyte
superoxide anion and nitric oxide production in environmentally
exposed children. Toxicol Appl Pharmacol. 245:244–251. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramos AM, Fernández C, Amrán D, Sancho P,
de Blas E and Aller P: Pharmacologic inhibitors of PI3K/Akt
potentiate the apoptotic action of the antileukemic drug arsenic
trioxide via glutathione depletion and increased peroxide
accumulation in myeloid leukemia cells. Blood. 105:4013–4020. 2005.
View Article : Google Scholar
|
|
13
|
Foti A, Bar-Eli M, Ahuja HG and Cline MJ:
A splicing mutation accounts for the lack of p53 gene expression in
a CML blast crisis cell line: a novel mechanism of p53 gene
inactivation. Br J Haematol. 76:143–145. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vogel CF, Sciullo E, Wong P, Kuzmicky P,
Kado N and Matsumura F: Induction of proinflammatory cytokines and
C-reactive protein in human macrophage cell line U937 exposed to
air pollution particulates. Environ Health Perspect. 113:1536–1541.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamamoto M, Hirano S, Vogel CF, Cui X and
Matsumura F: Selective activation of NF-kappaB and E2F by low
concentration of arsenite in U937 human monocytic leukemia cells. J
Biochem Mol Toxicol. 22:136–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solary E, Bertrand R, Kohn KW and Pommier
Y: Differential induction of apoptosis in undifferentiated and
differentiated HL-60 cells by DNA topoisomerase I and II
inhibitors. Blood. 81:1359–1368. 1993.PubMed/NCBI
|
|
17
|
Sordet O, Bettaieb A, Bruey JM, Eymin B,
Droin N, Ivarsson M, Garrido C and Solary E: Selective inhibition
of apoptosis by TPA-induced differentiation of U937 leukemic cells.
Cell Death Differ. 6:351–361. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sordet O, Rébé C, Leroy I, Bruey JM,
Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L and Solary E:
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass
the resistance of TPA-differentiated leukemic cells to apoptosis.
Blood. 97:3931–3940. 2001. View Article : Google Scholar
|
|
19
|
Iwama K, Nakajo S, Aiuchi T and Nakaya K:
Apoptosis induced by arsenic trioxide in leukemia U937 cells is
dependent on activation of p38, inactivation of ERK and the
Ca2+-dependent production of superoxide. Int J Cancer.
92:518–526. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fernández C, Ramos AM, Sancho P, Amrán D,
de Blas E and Aller P: 12-O-tetradecanoylphorbol-13-acetate may
both potentiate and decrease the generation of apoptosis by the
antileukemic agent arsenic trioxide in human promonocytic cells.
Regulation by extracellular signal-regulated protein kinases and
glutathione. J Biol Chem. 279:3877–3884. 2004.
|
|
21
|
Flora SJ: Arsenic-induced oxidative stress
and its reversibility. Free Radic Biol Med. 51:257–281. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Henderson P, Hale TW, Shum S and Habersang
RW: N-Acetylcysteine therapy of acute heavy metal poisoning in
mice. Vet Hum Toxicol. 27:522–525. 1985.PubMed/NCBI
|
|
23
|
Reddy PS, Rani GP, Sainath SB, Meena R and
Supriya Ch: Protective effects of N-acetylcysteine against
arsenic-induced oxidative stress and reprotoxicity in male mice. J
Trace Elem Med Biol. 25:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Banner W Jr, Koch M, Capin DM, Hopf SB,
Chang S and Tong TG: Experimental chelation therapy in chromium,
lead, and boron intoxication with N-acetylcysteine and other
compounds. Toxicol Appl Pharmacol. 83:142–147. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho SY, Wu WJ, Chiu HW, Chen YA, Ho YS, Guo
HR and Wang YJ: Arsenic trioxide and radiation enhance apoptotic
effects in HL-60 cells through increased ROS generation and
regulation of JNK and p38 MAPK signaling pathways. Chem Biol
Interact. 193:162–171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu YQ, You S, Zhang CL, Tashiro S,
Onodera S and Ikejima T: Oridonin enhances phagocytosis of
UV-irradiated apoptotic U937 cells. Biol Pharm Bull. 28:461–467.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirano S, Cui X, Li S, Kanno S, Kobayashi
Y, Hayakawa T and Shraim A: Difference in uptake and toxicity of
trivalent and pentavalent inorganic arsenic in rat heart
microvessel endothelial cells. Arch Toxicol. 77:305–312. 2003.
|
|
28
|
Riganti C, Aldieri E, Bergandi L, Tomatis
M, Fenoglio I, Costamagna C, Fubini B, Bosia A and Ghigo D: Long
and short fiber amosite asbestos alters at a different extent the
redox metabolism in human lung epithelial cells. Toxicol Appl
Pharmacol. 193:106–115. 2003. View Article : Google Scholar
|
|
29
|
Hirano S, Kobayashi Y, Cui X, Kanno S,
Hayakawa T and Shraim A: The accumulation and toxicity of
methylated arsenicals in endothelial cells: important roles of
thiol compounds. Toxicol Appl Pharmacol. 198:458–467. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosato RR, Almenara JA and Grant S: The
histone deacetylase inhibitor MS-275 promotes differentiation or
apoptosis in human leukemia cells through a process regulated by
generation of reactive oxygen species and induction of p21CIP1/WAF1
1. Cancer Res. 63:3637–3645. 2003.
|
|
31
|
Martin DS, Willis SE and Cline DM:
N-acetylcysteine in the treatment of human arsenic poisoning. J Am
Board Fam Pract. 3:293–296. 1990.PubMed/NCBI
|
|
32
|
United States Environmental Protection
Agency. Proven alternatives for aboveground treatment of arsenic in
groundwater. EPA-542-S-02-002. EPA; New York, NY, USA: 2002
|
|
33
|
Shiiki K, Yoshikawa H, Kinoshita H, Takeda
M, Ueno A, Nakajima Y and Tasaka K: Potential mechanisms of
resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic
leukemia HL-60 cells during granulocytic differentiation. Cell
Death Differ. 7:939–946. 2000. View Article : Google Scholar
|
|
34
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: a
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meinhardt G, Roth J and Hass R: Activation
of protein kinase C relays distinct signaling pathways in the same
cell type: differentiation and caspase-mediated apoptosis. Cell
Death Differ. 7:795–803. 2000. View Article : Google Scholar
|
|
37
|
Meinhardt G, Roth J and Totok G: Protein
kinase C activation modulates pro- and anti-apoptotic signaling
pathways. Eur J Cell Biol. 79:824–833. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takada Y, Hachiya M, Osawa Y, Hasegawa Y,
Ando K, Kobayashi Y and Akashi M:
12-O-tetradecanoylphorbol-13-acetate-induced apoptosis is mediated
by tumor necrosis factor alpha in human monocytic U937 cells. J
Biol Chem. 274:28286–28292. 1999. View Article : Google Scholar : PubMed/NCBI
|
